GROSSMAN ADAM S (President and CEO) sold 1.0% of their position (21K shares) of ADMA BIOLOGICS, INC. on the open market
Open‑market sale worth $336.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/21/2025ACC: 0001140361-25-042997
DirectorOfficer· President and CEO
Since Feb 2026
-21K
Net shares
Net seller
$336.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
15K acquired · 36K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+15K
Price / share
$5.40
Trade value
$81K
% of position
0.7%
11/19/2025
2.02M→2.03M
Common Stock
Direct
Shares
−15K
Price / share
$16.00
Trade value
$240K
% of position
0.7%
11/19/2025
2.03M→2.02M
Common Stock
Direct
Shares
−6K
Price / share
$16.00
Trade value
$96K
% of position
0.3%
11/19/2025
2.02M→2.01M
Total
Net shares
−6K
Net value
-$255K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2025 | M · Option Exercise | +15K | $5.40 | $81K | 0.7% | 2.02M | 2.03M |
| Common Stock Direct | 11/19/2025 | S · Sale | −15K | $16.00 | $240K | 0.7% | 2.03M | 2.02M |
| Common Stock Direct | 11/19/2025 | S · Sale | −6K | $16.00 | $96K | 0.3% | 2.02M | 2.01M |
| Total | −6K | -$255K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
5.4
Held after
735.95K
Exercisable
—
11/19/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock15K shares | 11/19/2025 | M · Option Exercise | −15K | 5.4 | — | 735.95K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.14M
Common Stock
IndirectShares owned580.96K
Total
1.72M indirect1.72M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.14M | Indirect |
| Common Stock | 580.96K | Indirect |
| Total | 1.72M | 1.72M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported